Raymond Leslie Zimmerman, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Main St, Miami, OK 74354 Phone: 918-540-9544 |
Melinda Monk Randle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Main St, Miami, OK 74354 Phone: 918-540-9544 Fax: 918-542-1188 |
Mrs. Suann Raylene Raff, DPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2301 S Eight Tribes Trl, Miami, OK 74354 Phone: 918-675-2021 |
Tim Heird, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1910 N Main St, Miami, OK 74354 Phone: 918-542-4795 Fax: 918-542-6019 |
Asheley Danielle Page, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Main St, Miami, OK 74354 Phone: 918-540-9544 Fax: 918-542-1166 |
Dr. Michael Wayne Frye, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 W Central Ave, Miami, OK 74354 Phone: 918-542-4444 |
News Archive
Last month, a three-judge panel ruled against the administration in the case Halbig v. Burwell, which is viewed as a blow to the Affordable Care Act. Meanwhile, Stateline reports that, based on that ruling, only those states with clear state-based exchange credentials are on solid legal footing.
Maximising the information captured from life and materials science samples is now possible with ease and simplicity, with the new Olympus UC90 microscope camera. Thanks to a range of innovative features, the UC90 excels in capturing and documenting real-life details, while a 4K UHD mode supports scientists in overcoming the limitations of the oculars with the many benefits of complete on-screen operation.
Governors have deep differences over national health care reform, but when it comes to so-called insurance exchanges — a centerpiece of the sprawling new federal law — nearly every state is moving ahead with implementation.
China Cord Blood Corporation ("CCBC" or "the Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its unaudited financial results for the quarter and six months ended September 30, 2009.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.
› Verified 7 days ago